November 16, 2021
The medical technology company Pentracor GmbH from Hennigsdorf wins the Zukunftspreis Brandenburg 2021, the most important business award in the state of Brandenburg. From 82 applicants and 12 finalists, the jury selected six prize winners and one company as a special prize winner. The award ceremony took place on November 12 at the Airport Center Berlin Schönefeld. "We are very honored by this award," said Dr. Ahmed Sheriff, Managing Director of Pentracor GmbH.
Worldwide unique therapy from Hennigsdorf
Pentracor's technology saves lives of Corona-infected patients in intensive care units. The blood washing process effectively reduces the loss of tissue after heart attacks or strokes and thus preserves the performance capacity of the people affected. Pentracor's CRP apheresis can be an efficient therapeutic aid in other inflammatory diseases of the intestine (ulcerative colitis and Crohn's disease), the pancreas and rheumatoid diseases. "I almost can't imagine intensive care medicine without CRP apheresis anymore," says Fabrizio Esposito, MD, the head physician of intensive care and emergency medicine, as well as a cardiologist, at Havelhöhe Hospital in Berlin. He has successfully treated numerous patients with Pentracor's blood washing procedure. "Currently, 16 clinics from the Allgäu region in the south to Flensburg in the north, including university hospitals, are using the blood washing procedure with continuously growing success. The trend for further clinic partners is increasing, as are sales," explains Dr. Sheriff. The Austrian university hospitals of Innsbruck, Salzburg and Graz are currently working on a large-scale study with CRP apheresis after myocardial infarction.
Innovation based on new basic research
Pentracor is the only company in the world that can specifically reduce the amount of CRP in the body. The background to Pentracor's groundbreaking therapy is a novel insight into the role of the protein CRP, supported by various studies. According to this understanding, this protein molecule, in an extension of the medical textbook opinion, not only serves as a measure of the severity of an inflammation and for marking inflamed tissue and subsequent removal by the scavenger cells of the no longer viable inflamed cells. Rather, CRP also functions as a trigger amplifying the inflammatory events of various diseases. CRP is then frequently involved in the cell death of still viable as well as healthy cells in inflammatory events. The problem is always characterized by a strongly increased synthesis of CRP.
The partners of the most important business award in Brandenburg include the six chambers of commerce - IHKs and HwKs - as well as renowned institutions such as the Wirtschaftsförderung Land Brandenburg GmbH. In addition, companies, banks, employment agencies in the state of Brandenburg and several media partners are among the circle of supporters.
The award was widely reported in the german press, including at the Medicom VerlagsgmbH and in detail in the "Märkische Allgemeine Zeitung.(German)
Furthermore, in december, at Brandenburg Kapital and within the MOZ as well as the Oranienburger Generalanzeiger (German).
Further Inquiries & Contact:
Pentracor GmbH
CEO Dr. Ahmed Sheriff
+49 3302 20944930
sheriff@pentracor.de
